Business, energy, technology, markets and global industry news from Business News Today

American Society of Clinical Oncology

PharmaDeviceNews American Society of Clinical Oncology
AnHorn Medicines has begun first-in-human testing of AH-008 as the biotechnology company investigates whether the experimental therapy could help prevent chemotherapy-induced peripheral neuropathy. Representative image.
Pharma & Biotech

AnHorn Medicines doses first participant in Phase 1 AH-008 CIPN prevention trial

AnHorn Medicines doses the first participant in a Phase 1 AH-008 study, opening a cautious clinical test of chemotherapy neuropathy prevention.

Read More
Representative image of oncology researchers analysing cancer imaging and laboratory data as SalubrisBio’s JK06 antibody drug conjugate shows early Phase 1/2 promise in 5T4-targeted treatment for lung cancer and breast cancer.
Pharma & Biotech

SalubrisBio’s JK06 shows early promise, but can 5T4 ADCs move beyond niche excitement?

Find out how SalubrisBio’s JK06 data could reshape 5T4-targeted ADC development in lung and breast cancer.

Read More
Representative image: INOVIO Pharmaceuticals’ upcoming ASCO and ASGCT conference posters place INO-3107 DNA immunotherapy and early hemophilia A gene transfer research under the spotlight as investors watch the biotech firm’s regulatory and platform strategy.
Pharma & Biotech

INOVIO’s ASCO and ASGCT updates may sharpen scrutiny of its DNA medicine strategy

INOVIO has a regulatory clock ticking. New INO-3107 and hemophilia A data may show whether its DNA platform can move beyond promise.

Read More